ANZGOG was established to improve gynaecological cancer treatment and outcomes for women in Australia and New Zealand.
In 2000 there were limited clinical trials available for women in Australasia. Cancer specialists felt that Australian and New Zealand women were missing out on the latest treatment options being offered in clinical trials in other parts of the world.
Trials were established through a cooperative approach with other clinical trial groups, participation in overseas clinical trials and multidisciplinary research.
Initially ANZGOG worked as an Advisory Group for the National Health and Medical Research Council (NHMRC) Clinical Trials Centre (CTC) at the University of Sydney.
In August 2009, ANZGOG became an incorporated not-for-profit company limited by guarantee.
Governance is now independent of the University of Sydney, although the group continues to maintain its former collaborative relationship with the CTC operating trials on behalf of ANZGOG. The CTC Program Manager, Dr Julie Martyn, oversees the coordination of ANZGOG clinical trials.
The ANZGOG Board of Directors directs all Group activities. A number of committees are charged with carrying out the objectives of ANZGOG, they are led by Directors and report to the Board.
ANZGOG is managed on behalf of the Board, by the Executive Officer, Ms Alison Evans. The management office is situated in the Chris O'Brien Lifehouse in Camperdown, Sydney.